Acanthosis nigricans associated with hepatolenticular degeneration

Journal of Dermatology

Volumn 24, Issue 6, 1997, Pages 395-400

  Thaipisuttikul, Yupin ^a  

^a RAJAVITHI HOSPITAL   (Thailand)

Author keywords

Acanthosis nigricans; Hepatolenticular degeneration

Indexed keywords

CERULOPLASMIN; COPPER; PENICILLAMINE;

ACANTHOSIS NIGRICANS; ADOLESCENT; ARTICLE; AXILLA; CASE REPORT; COPPER BLOOD LEVEL; DISEASE ASSOCIATION; FOOT; HUMAN; HUMAN TISSUE; HYPERKERATOSIS; LIVER FUNCTION TEST; MALE; ORAL DRUG ADMINISTRATION; PAPILLOMATOSIS; SKIN BIOPSY; SKIN DEFECT; URINE LEVEL; WILSON DISEASE;

EID: 0030757862     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.1997.tb02810.x     Document Type: Article

References (28)

1. Curtis AC, Richards HJ: Acanthosis nigricans, Cutis, 3: 147-160, 1967.
2. Kozlowski LM, Nigra TP: Esophageal acanthosis nigricans in association with adenocarcinoma from an unknown primary site, J Am Acad Dermatol, 26: 348-351, 1992.
3. Moller DE, Flier JS: Insulin resistance-mechanisms, syndromes, and implications, N Engl J Med, 325: 938-948, 1991.
4. Matsuoka LY, Goldman J, Wortsman J, et al: Antibodies against the insulin receptor in paraneoplastic acanthosis nigricans, Am J Med, 82: 1253-1256, 1987.
5. Schwartz RA: Acanthosis nigricans, in Demis DJ (eds): Clinical Dermatology, 18th ed, Philadelphia, JB Lippincott, 1991, (unit 12-26) pp 1-11.
6. Fleming MG, Simon SI: Cutaneous insulin reaction resembling acanthosis nigricans, Arch Dermatol, 122: 1054-1056, 1986.
7. Ifrah N, Berger F, Saint-Andre JP, et al: Transient acanthosis nigricans following bone marrow transplantation for lymphoid malignancy, Bone Marrow Transplant, 5: 281-282, 1990.
8. Rendon MI, Cruz PD, Sontheimer RD, et al: Acanthosis nigricans: A cutaneous marker of tissue resistance to insulin, J Am Acad Dermatol, 21: 461-469, 1989.
9. Golding DN, Walshe JM: Arthropathy of Wilson's disease, study of clinical and radiological features in 32 patients, Ann Rheum Dis, 36: 99-111, 1977.
10. Pollitzer S: Acanthosis nigricans, in Unna PG, Morris M, Besnier E, et al (eds): International Atlas of Rare Skin Diseases, London, HK Lewis & C, 1890, (chapter 10) pp 1-3.
11. Mukai T: Acanthosis nigricans, Acta Derma (Kyoto), 14: 447-460, 1929.
12. Lerner AB: On the cause of acanthosis nigricans, N Engl J Med, 281: 106-107, 1969.
13. Brown T, Winkelmann RK: Acanthosis nigricans: A study of 90 cases, Medicine, 47: 33-51, 1968.
14. Winkelmann RK, Scheen SR, Underdahl LO: Acanthosis nigricans and endocrine disease, JAMA, 174: 67-74, 1960.
15. Flier JS: Metabolic importance of acanthosis nigricans, Arch Dermatol, 121: 93-94, 1985.
16. Accili D, Barbetti F, Cama A, et al: Mutations in the insulin receptor gene in patients with genetic syndromes of insulin resistance and acanthosis nigricans, J Invest Dermatol, 98 (suppl): 77s-81s, 1992.
17. Cruz PD Jr, Hud JA Jr: Excess insulin binding to insulin-like growth factor receptors, proposed mechanism for acanthosis nigricans, J Invest Dermatol, 98 (suppl): 77s-81s, 1992.
18. Rendon MI, Cruz PD, Sontheimer RD, et al: Acanthosis nigricans, a cutaneous marker of tissue resistance to insulin, J Am Acad Dermatol, 48: 465-473, 1989.
19. Ezzo A, Rowley JF, Finnegan JV: Hepatolenticular degeneration associated with acanthosis nigricans, AMA Arch Intern Med, 100: 827-832, 1957.
20. Tanzi RE, Petrukhin K, Chernov I, et al: The Wilson's disease gene is a copper transporting ATPase with homology to the Menkes disease gene, Nat Genet, 5: 344-350, 1993.
21. Sokol RJ: Wilson's disease and Indian childhood cirrhosis, in Suchy FJ (eds): Liver Disease in Children, St. Louis, Mosby, 1994, pp 747-772.
22. Scheinberg IH, Sternlieb I: Wilson's Disease, W.B. Saunders, Philadelphia, 1984.
23. Walsh JM: The liver in Wilson's disease, in Schiff L, Schiff ER (eds): Diseases of the Liver, JB Lippincott, Philadelphia, 1982, pp 1043-1060.
24. Scheinberg IH, Sternlieb I, Schilsky M, et al: Penicillamine may detoxify copper in Wilson's disease, Lancet, 2: 95, 1987.
25. Schoen RE, Sternlieb I: Clinical aspects of Wilson's disease, Am J Gastroenterol, 85: 1453-1457, 1990.
26. Dubois RS, Rodgerson DO, Hambidge KM: Treatment of Wilson's disease with triethylene tetramine hydrochloride (Trientine), J Pediatr Gastroenterol Nutr, 10: 77-81, 1990.
27. Veen C, Van den Hamer CJA, Leeuw PW: Zinc sulphate therapy for Wilson's disease after acute deterioration during treatment with low-dose D-penicillamine, J Intern Med, 229: 549-552, 1991.
28. Walske JM: Thiomolybdates in the treatment of Wilson's disease, Arch Neurol, 49: 132, 1992.